Bifogade filer
PDF
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
ADDvise Group AB (publ) (the "Company" and together with its subsidiaries from time to time, the "Group") has instructed the agent for the Company's senior secured bonds with ISIN SE0015222088 (the "Bonds") to initiate a written procedure to request that bondholders vote in favour of inter alia (i) increasing the framework from SEK 500 million to SEK 650 million and waiving the requirement to meet the Incurrence Test in connection with the contemplated issue of subsequent Bonds under the increased framework, and (ii) amending and restating certain permitted debt baskets which, on a net basis, will not result in an increase in total permitted interest bearing debt (the "Proposal").
Bondholders together representing approximately 50 per cent of the outstanding volume under the Bonds have expressed their support for the Proposal.
The agent will deliver the notice of a written procedure to all bondholders on 21 November 2022. The written procedure will commence on 25 November 2022 and end on 15 December 2022. To be eligible to participate in the written procedure a holder must fulfil the formal criteria for being a bondholder on 25 November 2022. This means that the holder must be registered on a securities account with Euroclear Sweden AB as a direct registered owner (Sw. direktregistrerad ägare) or authorised nominee (Sw. förvaltare) with respect to one or several Bonds.
Pareto Securities AB has been retained as financial advisor in connection with the written procedure.
The notice of a written procedure is available on the Company's website (addvisegroup.com) and on website of the agent (intertrustgroup.com).
For further information, please contact:
Rikard Akhtarzand, CEO
+46765-25 90 71
rikard.akhtarzand@addvisegroup.se
Hanna Myhrman, General Counsel
+46 709-82 92 23
hanna.myhrman@addvisegroup.se
Important information:
This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on 21 November 2022 at 17:45 CET.
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The Group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expanding the business - both geographically and product-wise. ADDvise Group's shares are listed on Nasdaq First North Premier Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se,is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.
.